BRIEF published on 07/01/2024 at 12:15, 2 years 4 months ago GAUSSIN reporte l'approbation de ses comptes 2023 au 31 octobre 2024 Report Comptes 2023 GAUSSIN Penalty Bench Procédures De Sauvegarde
BRIEF published on 07/01/2024 at 12:15, 2 years 4 months ago GAUSSIN postpones the approval of its 2023 accounts until October 31, 2024 Postponement 2023 Accounts GAUSSIN Penalty Bench Backup Procedures
BRIEF published on 07/01/2024 at 12:15, 2 years 4 months ago Report de l'approbation des comptes 2023 au 31 octobre 2024 pour GAUSSIN Euronext Report Comptes 2023 GAUSSIN Procédures De Sauvegarde
BRIEF published on 07/01/2024 at 12:15, 2 years 4 months ago Postponement of approval of the 2023 accounts to October 31, 2024 for GAUSSIN Euronext Report 2023 Accounts GAUSSIN Backup Procedures
BRIEF published on 07/01/2024 at 12:11, 2 years 4 months ago Guillemot Corporation: Weekly Share Buyback Report from June 24 to June 28, 2024 Euronext Paris Share Buyback Financial Report Guillemot Corporation June 2024
BRIEF published on 07/01/2024 at 12:11, 2 years 4 months ago Guillemot Corporation : Récapitulatif des Transactions sur Actions Propres Actions Propres Rachat D'actions Euronext Paris Guillemot Corporation Règlement MAR
BRIEF published on 07/01/2024 at 12:07, 2 years 4 months ago CS MEDICA Stock Now Also Traded on XETRA Liquidity Trading XETRA CS MEDICA A/S Hauck Aufhäuser Lampe
BRIEF published on 07/01/2024 at 12:07, 2 years 4 months ago L'action CS MEDICA est désormais également négociée sur XETRA Liquidité XETRA Commerce CS MEDICA A/S Lampe Aufhäuser Hauck
BRIEF published on 07/01/2024 at 12:02, 2 years 4 months ago Dr Martin Paal Starts as the New Chief Financial Officer of GRENKE AG Chief Financial Officer Finance Banking GRENKE AG Dr Martin Paal
BRIEF published on 07/01/2024 at 12:02, 2 years 4 months ago Dr Martin Paal devient le nouveau directeur financier de GRENKE AG Finance GRENKE AG Directeur Financier Dr Martin Paal Bancaire
Published on 11/10/2026 at 11:00, 11 minutes ago 3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
Published on 11/10/2026 at 08:00, 3 hours 11 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 8 hours 26 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:00, 12 hours 11 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/10/2026 at 11:04, 6 minutes ago aap increases revenue by 2% in the third quarter of 2026 – on top of the already high prior-year level
Published on 11/10/2026 at 10:50, 21 minutes ago German R&D Tax Credits: New Administrative Instruction by Federal Ministry of Finance Tightens Documentation Requirements
Published on 11/10/2026 at 10:09, 1 hour 1 minute ago EQS-Adhoc: Emerald Horizon AG plans to raise approximately EUR 135 million in equity by 2028 and resolves first cash capital increase
Published on 11/10/2026 at 10:08, 1 hour 2 minutes ago Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
Published on 11/10/2026 at 11:02, 8 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 8 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 4 hours 11 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 4 hours 11 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 16 hours 41 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
